Medindia
Medindia LOGIN REGISTER
Advertisement

Possible Cannabis Reform Heats Up

Wednesday, October 26, 2016 Drug News
Advertisement
NEW YORK, October 26, 2016 /PRNewswire/ --
Advertisement

http://www.Financialbuzz.com - This election is shaping up to be a possible turning point for the future of cannabis legislation in the United States. Reforms on cannabis legalization are on the ballot in nine states this year. The states where recreational marijuana is on the ballot are California, Arizona, Nevada, Maine and Massachusetts, while North Dakota, Arkansas, Montana and Florida are considering medical marijuana. ChineseInvestors.com Inc. (OTC: CIIX), Medicine Man Technologies, Inc. (OTCQB: MDCL), Cara Therapeutics Inc. (NASDAQ: CARA), Terra Tech Corp. (OTC: TRTC), United Cannabis Corp. (OTCQB: CNAB)
Advertisement

These states may influence the politics of other states, as all the nine states constitute approximately a quarter of the entire population of the country and polls show that the movement advocating for cannabis legalization has gathered enough momentum over the years to finally influence political decisions. According to recent polls, about 57 percent of adults say cannabis should be legal.

As a result it is not surprising that companies who have invested in cannabis companies are now in a better position to benefit from the new political climate. A key potential catalyst for ChineseInvestors.com Inc. (OTCQB: CIIX) for example, was the strategic investment into a recent public listing of Medicine Man Technologies, Inc. (OTCQB: MDCL), a cannabis branding and consulting company that boasts 24 clients and a market capitalization of $17.8mn as of October 10, 2016.

ChineseInvestors.com Inc. specializes in providing real-time market commentary and analysis in the Chinese language. The Company offers subscription services to provide education about investing and news. The Company's service offerings permit users to subscribe to several of its service packages. Earlier this August, the company announced that their live streaming service has helped the company book record subscription revenues the month before.

Other cannabis companies are also gaining in popularity. Cara Therapeutics Inc. (NASDAQ: CARA) possesses both near-term clinical development opportunities, united with proprietary approaches to developing innovative novel therapeutics. Cara's most advanced patented compound, CR845, is now undergoing clinical testing for acute pain and pruritus. This compound possesses analgesic, anti-inflammatory and anti-pruritic activities appropriate for multiple therapeutic applications. The company's ambitions are to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

Integrated cannabis-focused agriculture company, Terra Tech Corp. (OTCQX: TRTC) announced the Grand Opening of its Blüm retail dispensary, located in Nevada. This marks the company's third retail location in Nevada and follows the opening of the Western Las Vegas Dispensary in April, 2016 and the South Decatur Boulevard Las Vegas Dispensary in August, 2016. The Company also operates a Blüm dispensary in Oakland, California.

United Cannabis Corp. (OTCQB: CNAB) will begin processing industrial hemp to excerpt cannabinoids, terpenes, along with other compounds for the use in its products. Hemp is a Cannabis Sativa and the 2014 U.S. Farm Bill distinguishes industrial hemp, defining it as "a plant of the genus cannabis and any part of the plant, whether growing or not, containing a delta-9 tetrahydrocannabinol concentration of no more than three-tenths of one percent on a dry weight basis."

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

For "The Latest Buzz in Financial News", SIGN UP & Visit: http://www.FinancialBuzz.com

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com     

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. Financialbuzz.com has not been compensated for financial news dissemination and pr services by any of the companies mentioned this release. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information:

Media Contact: [email protected] , +1-877-601-1879

SOURCE FinancialBuzz.com

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close